Canine genomics co. scores $75M in fundingJuly 29, 2021A canine genomics and biotechnology company hoping to increase the lifespan of dogs by three years within the next decade has raised $75 million in Series B funding.
SPONSORED CONTENTOne dose protects for 12 months.One ProHeart® 12 (moxidectin) injection puts compliance in your control. + Get started
Canine genetics, health to be explored at summitFebruary 9, 2021Preserving and enhancing genetic diversity in dog breeds is set to be explored at an upcoming virtual educational conference.